adalimumab (HUMIRA®) [clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c]
intervention [clinicaltrials_vocabulary:intervention]
adalimumab (HUMIRA®) [clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c]
Bio2RDF identifier
00412a0337593c304b3e8ca2a934e97c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
The primary objective of the s ...... der usual practice conditions.
intervention name [clinicaltrials_vocabulary:intervention-name]
adalimumab (HUMIRA®)
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c
title
adalimumab (HUMIRA®)
@en
type
label
adalimumab (HUMIRA®) [clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c]
@en